[Experimentation with 2-formyl-17(alpha)-methylandrosta-1,4-dien-11(alpha), 17(beta)-diol-3-one in geriatric clinic].
D000367:Age Factors; D000368:Aged; D000734:Androstenediols / Q000627:therapeutic use*; D001796:Blood Protein Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D005561:Formates / Q000627:therapeutic use; D006801:Humans; D007664:Ketosteroids / Q000627:therapeutic use; D008297:Male
D000734:Androstenediols; D005561:Formates; D007664:Ketosteroids
Sperimentazione con 2-formil-17(alfa)-metilandrosta-1,4-dien-11(alfa), 17(beta)-diol-3-one in clinica geriatrica